CXCL12-abundant reticular cells are the major source of IL-6 upon LPS stimulation and thereby regulate hematopoiesis.
Rahel C GerosaSteffen BoettcherLarisa V KovtonyukAnnika HausmannWolf-Dietrich HardtJuan HidalgoCésar Nombela-ArrietaMarkus G ManzPublished in: Blood advances (2022)
Hematopoiesis is maintained by hematopoietic stem and progenitor cells that are located in the bone marrow (BM) where they are embedded within a complex supportive microenvironment consisting of a multitude of various non-hematopoietic and hematopoietic cell types. The BM microenvironment not only regulates steady-state hematopoiesis by provision of growth factors, cytokines, and cell-cell contact but is also an emerging key player during the adaptation to infectious and inflammatory insults (emergency hematopoiesis). Through a combination of gene expression analyses in prospectively isolated non-hematopoietic BM cell populations and various mouse models, we found that BM CXCL12-abundant reticular (CAR) cells are a major source of systemic and local BM interleukin-6 (IL-6) levels during emergency hematopoiesis after lipopolysaccharide (LPS) stimulation. Importantly, although IL-6 is dispensable during the initial phase of LPS-induced emergency hematopoiesis, it is required to sustain an adequate hematopoietic output during chronic repetitive inflammation. Our data highlight the essential role of the non-hematopoietic BM microenvironment for the sensing and integration of pathogen-derived signals into sustained demand-adapted hematopoietic responses.
Keyphrases
- bone marrow
- lps induced
- inflammatory response
- single cell
- gene expression
- stem cells
- emergency department
- cell therapy
- public health
- induced apoptosis
- oxidative stress
- mesenchymal stem cells
- hematopoietic stem cell
- cell proliferation
- machine learning
- toll like receptor
- palliative care
- big data
- deep learning
- immune response
- cell death